Match!
Sang Gyune Kim
Soonchunhyang University Hospital
Hepatocellular carcinomaDiabetes mellitusGeneral surgeryMedicineGastroenterology
90Publications
14H-index
544Citations
What is this?
Publications 92
Newest
#1Minseok Kim (Seoul National University Hospital)H-Index: 30
#1Minseok Albert Kim (Seoul National University Hospital)
Last. Sang Gyune Kim (Soonchunhyang University Hospital)H-Index: 14
view all 31 authors...
Objective Direct comparison of the clinical outcomes between nucleos(t)ide analogue (NA) discontinuation versus NA continuation has not been performed in patients with chronic hepatitis B who achieved HBsAg-seroclearance. Whether NA discontinuation was as safe as NA continuation after NA-induced surface antigen of HBV (HBsAg) seroclearance was investigated in the present study. Designs This multicentre study included 276 patients from 16 hospitals in Korea who achieved NA-induced HBsAg seroclear...
Source
#1Yoo JeH-Index: 1
#1Jeong Ju YooH-Index: 12
Last. Young Don KimH-Index: 8
view all 11 authors...
The use of beta-blockers in decompensated cirrhosis accompanying ascites is still under debate. The aim of this study was to compare overall survival (OS) and incidence of cirrhotic complications between endoscopic variceal ligation (EVL) only and EVL + non-selective beta-blocker (NSBB) combination therapy in cirrhotic patients with significant ascites (≥grade 2). This retrospective study included 271 consecutive cirrhotic patients with ascites who were treated with EVL only or EVL + NSBB combin...
Source
#1Baek Gyu JunH-Index: 5
#2Eui Ju ParkH-Index: 4
Last. Boo Sung KimH-Index: 17
view all 14 authors...
BACKGROUND/AIMS: This study was conducted to clarify the sustained virological response (SVR) prediction ability of baseline and treatment-related factors in patients with chronic hepatitis C virus (HCV) infection. METHODS: This retrospective study collected data at four tertiary referral hospitals between June 2004 and July 2012. Out of 476 patients, 330 treatment-naive patients with chronic HCV infection were recruited. Pegylated interferon α-2a/- 2b plus ribavirin was administered for either ...
Source
#1E.L. YoonH-Index: 4
#2Dae Won JunH-Index: 23
Last. Yong Kyun ChoH-Index: 27
view all 15 authors...
Source
#2Yeon Seok SeoH-Index: 24
Last. Seung U. KimH-Index: 81
view all 43 authors...
Source
#1Yoo JeH-Index: 1
#2Yung-soo KimH-Index: 75
Last. Yang Soo KimH-Index: 104
view all 4 authors...
Source
#1Yoo JeH-Index: 1
#2Sang Gyune KimH-Index: 14
Last. Yung-soo KimH-Index: 75
view all 3 authors...
Source
#2Seong Hee KangH-Index: 6
Last. S.Y. ParkH-Index: 1
view all 11 authors...
Source
#1Do Seon SongH-Index: 2
#2Tae Yeob KimH-Index: 16
Last. Dong Joon KimH-Index: 27
view all 15 authors...
Source
#1Yang Soo Kim (Catholic University of Korea)H-Index: 104
#2Myeong Jun Song (Catholic University of Korea)H-Index: 16
Last. Eun-Young Cho (Wonkwang University)H-Index: 9
view all 23 authors...
Aims To evaluate the efficacy and safety of 144-week tenofovir disoproxil fumarate (TDF) therapy in treatment-naive chronic hepatitis B (CHB) patients in Korean.
Source
12345678910